Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis

Clinical Science

Volumn 106, Issue 1, 2004, Pages 27-34

  Pantaleo, Pietro ^a   Marra, Fabio ^a   Vizzutti, Francesco ^a   Spadoni, Saura ^a   Ciabattoni, Giovanni ^b   Galli, Claudio ^c   La Villa, Giorgio ^a   Gentilini, Paolo ^a   Laffi, Giacomo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Ascites; Cirrhosis; Diuretics; Platelet aggregation; Prostaglandin; Renal function; Thromboxane

Indexed keywords

11 OXOTHROMBOXANE B2; 6 OXOPROSTAGLANDIN F1 ALPHA; 8 ISOPROSTAGLANDIN F2 ALPHA; ARACHIDONIC ACID; COLLAGEN; DIURETIC AGENT; FATTY ACID; FUROSEMIDE; LIPID; MEMBRANE PHOSPHOLIPID; OLEIC ACID; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN F1 ALPHA; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; KIDNEY FUNCTION; LIPID BLOOD LEVEL; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEMBRANE; METABOLITE; PATIENT; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; URINARY EXCRETION; URINE;

AGED; ARACHIDONIC ACID; DIETARY SUPPLEMENTS; DIURETICS; DOUBLE-BLIND METHOD; FATTY ACIDS; FEMALE; FUROSEMIDE; HUMANS; KIDNEY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PHOSPHOLIPIDS; PLATELET AGGREGATION; PROSTAGLANDINS;

EID: 0346494718     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20030182     Document Type: Article

References (37)

1. De Franchis, R. and Primignani, M. (2001) Natural history of portal hypertension in patients with cirrhosis. Clin. Liver Dis. 5, 645-663
2. Gentilini, P., Laffi, G., La Villa, G. et al. (1997) Long course and prognostic factors of virus-induced cirrhosis of the liver. Am. J. Gastroenterol. 92, 66-72
3. Kelly, D. A. and Tuddenham, E. G. (1986) Haemostatic problems in liver disease. Gut 27, 339-349
4. Rubin, M. H., Weston, M. J., Langley, P. G., White, Y. and Williams, R. (1979) Platelet function in chronic liver disease: relationship to disease severity. Dig. Dis. Sci. 24, 197-202
5. Laffi, G., Cominelli, F., Ruggiero, M. et al. (1988) Altered platelet function in cirrhosis of the liver: impairment of inositol lipid and arachidonic acid metabolism in response to agonists. Hepatology 8, 1620-1626
6. Laffi, G., Marra, F., Gresele, P. et al. (1992) Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation. Gastroenterology 103, 641-646
7. Owen, J. S., Mutton, R. A., Day, R. C., Bruckdorfer, K. R. and McIntyre, N. (1981) Platelet lipid composition and platelet aggregation in human liver disease. J. Lipid Res. 22, 423-430
8. Owen, J. S., Bruckdorfer, K. R., Day, R. C. and McIntyre, N. (1982) Decreased erythrocyte membrane fluidity and altered lipid composition in human liver disease. J. Lipid Res. 23, 124-132
9. Laffi, G., La Villa, G., Pinzani, M., Marra, F. and Gentilini, P. (1997) Arachidonic acid derivatives and renal function in liver cirrhosis. Semin. Nephrol. 17, 530-548
10. Laffi, G., La Villa, G., Pinzani, M. et al. (1986) Altered renal and platelet arachidonic acid metabolism in cirrhosis. Gastroenterology 90, 274-282
11. 2 in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome). J. Hepatol. 3, 111-117
12. 2 and prostacyclin in decompensated liver disease and hepatorenal syndrome. Gastroenterology 100, 1069-1077
13. Harry, D. S. and McIntyre, N. (1999) Plasma lipids and lipoproteins. In Oxford Textbook of Clinical Hepatology (Bircher. J., Benhamou, J. P., McIntyre, N., Rizzetto, M. and Rodes, J., eds.), pp. 287-301, Oxford University Press, Oxford
14. Kawata, S., Chitranukroh, A., Owen, J. S. and McIntyre, N. (1987) Membrane lipid changes in erythrocytes, liver and kidney in acute and chronic experimental liver disease in rats. Biochim. Biophys. Acta 896, 26-34
15. Cabre, E., Abad-Lacruz, A., Nunez, M. C. et al. (1993) The relationship of plasma polyunsaturated fatty acid deficiency with survival in advanced liver cirrhosis: multivariate analysis. Am. J. Gastroenterol. 88, 718-722
16. Alvaro, D., Angelico, M., Attili, A. F., De Santis, A., Pieche, U. and Capocaccia, L. (1982) Abnormalities in erythrocyte membrane phospholipids in patients with liver cirrhosis. Biochem. Med. 28, 157-164
17. Kinsella, J. E., Lokesh, B. and Stone, R. A. (1990) Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms. Am. J. Clin. Nutr. 52, 1-28
18. Kinsella, J. E., Lokesh, B., Broughton, S. and Whelan, J. (1990) Dietary polyunsaturated fatty acids and eicosanoids: potential effects on the modulation of inflammatory and immune cells: an overview. Nutrition 6, 24-44
19. Kinsella, J. E., Broughton, S. and Whelan, J. (1990) Dietary unsaturated fatty acids: interaction and possible needs in relation to eicosanoid synthesis. J. Nutr. Biochem. 1, 123-141
20. Marra, F., Riccardi, D., Melani, L. et al. (1998) Effects of supplementation with unsaturated fatty acids on plasma and membrane lipid composition and platelet function in patients with cirrhosis and defective aggregation. J. Hepatol. 28, 654-661
21. Whelan, J., Li, B. and Birdwell, C. (1997) Dietary arachidonic acid increases eicosanoid production in the presence of equal amounts of dietary eicosapentaenoic acid. Adv. Exp. Med. Biol. 400B, 897-904
22. Whelan, J., Surette, M. E., Hardardottir, I. et al. (1993) Dietary arachidonate enhances tissue arachidonate levels and eicosanoid production in Syrian hamsters. J. Nutr. 123, 2174-2185
23. Seyberth, H. W., Oelz, O., Kennedy, T. et al. (1975) Increased arachidonate in lipids after administration to man: effects on prostaglandin biosynthesis. Clin. Pharmacol. Ther. 18, 521-529
24. Folch, J., Lees, M. and Sloane Stanley, G. H. (1957) A simple method for the isolation and purification of total lipids from animal tissue. J. Biol. Chem. 226, 497-509
25. Laffi, G., Marra, F., Failli, P. et al. (1993) Defective signal transduction in platelets from cirrhotics is associated with increased cyclic nucleotides. Gastroenterology 105, 148-156
26. 2α excretion in man. J. Pharmacol. Exp. Ther. 275, 94-100
27. 2 in human plasma and urine. Biochim. Biophys. Acta 918, 293-297
28. Pugh, R. N., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C. and Williams, K. (1973) Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 60, 646-649
29. Shiraishi, K., Matsuzaki, S., Itakura, M. and Ishida, H. (1996) Abnormality in membrane fatty acid compositions of cells measured on erythrocyte in alcoholic liver disease. Alcohol Clin. Exp. Res. 20, 56A-59A
30. Italian Multicentre Cooperative Project on nutrition in liver cirrhosis (1994) Nutritional status in cirrhosis. J. Hepatol. 21, 317-325
31. 2 activity in rats with cirrhosis and ascites. Hepatology 27, 42-47
32. 2 activity in rats. J. Clin. Invest. 98, 365-371
33. Laffi, G., Cinotti, S., Filimberti, E. et al. (1996) Defective aggregation in cirrhosis is independent of in vivo platelet activation. J. Hepatol. 24, 436-443
34. Davi, G., Ferro, D., Basili, S. et al. (1998) Increased thromboxane metabolites excretion in liver cirrhosis. Thromb. Haemostasis 79, 747-751
35. Lawson, J. A., Rokach, J. and FitzGerald, G. A. (1999) Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo. J. Biol. Chem. 274, 24441-24444
36. 2- isoprostanes) in the hepatorenal syndrome. J. Lipid Mediat. 6, 417-420
37. Pratico, D., Iuliano, L., Basili, S. et al. (1998) Enhanced lipid peroxidation in hepatic cirrhosis. J. Invest. Med. 46, 51-57